Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view

What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychiatry and clinical neurosciences 2014-01, Vol.68 (1), p.1-20
Hauptverfasser: Yamamoto, Ken‐ichi, Shinba, Toshikazu, Yoshii, Mitsunobu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 20
container_issue 1
container_start_page 1
container_title Psychiatry and clinical neurosciences
container_volume 68
creator Yamamoto, Ken‐ichi
Shinba, Toshikazu
Yoshii, Mitsunobu
description What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti‐noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long‐term noradrenergic dysfunction.
doi_str_mv 10.1111/pcn.12126
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1492623276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1490708266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5116-662d55356a3866cc59d42ffd99285a5a7280ddc3a7c17517d6bb04349665138d3</originalsourceid><addsrcrecordid>eNqN0U9LwzAYBvAgipvTg19ACl700C1v0qSttzH8B0N30HPJktR1tE1NWke_vZmbHgTBXBJ4fzwkeRA6BzwGvyaNrMdAgPADNIQowiEkkB76MyU0BAp8gE6cW2OMKeVwjAYkojFJUj5E84Xr5aoQrS1k4PqqaU3lApMHtbFCWV1r--Ynqnd5V8u2MPVNMA0a0a5Ms-pdYUrj56IMPgq9OUVHuSidPtvvI_R6d_syewjnz_ePs-k8lAyAh5wTxRhlXNCEcylZqiKS5ypNScIEE_5qWClJRSwhZhArvlziiEYp5wxoougIXe1yG2veO-3arCqc1GUpam06l0GUEk4oifl_KI5xQviWXv6ia9PZ2j_EqzhimGAgXl3vlLTGOavzrLFFJWyfAc62bWS-jeyrDW8v9ondstLqR35_vweTHdgUpe7_TsoWs6dd5CeGA5Hr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1474502012</pqid></control><display><type>article</type><title>Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Open Access Titles of Japan</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Yamamoto, Ken‐ichi ; Shinba, Toshikazu ; Yoshii, Mitsunobu</creator><creatorcontrib>Yamamoto, Ken‐ichi ; Shinba, Toshikazu ; Yoshii, Mitsunobu</creatorcontrib><description>What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti‐noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long‐term noradrenergic dysfunction.</description><identifier>ISSN: 1323-1316</identifier><identifier>EISSN: 1440-1819</identifier><identifier>DOI: 10.1111/pcn.12126</identifier><identifier>PMID: 24372896</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Adrenergic Neurons - drug effects ; Adrenergic Neurons - pathology ; Animals ; Anti-Anxiety Agents - pharmacology ; Anti-Anxiety Agents - therapeutic use ; Antipsychotic Agents - pharmacology ; Antipsychotic Agents - therapeutic use ; Anxiety ; Arousal - drug effects ; Arousal - physiology ; Behavioral Symptoms - drug therapy ; Behavioral Symptoms - physiopathology ; Humans ; hyperarousal symptoms ; Hypotheses ; locus coeruleus ; Mental Disorders - complications ; Mental Disorders - drug therapy ; Mental Disorders - physiopathology ; Mental Disorders - psychology ; noradrenaline ; pathophysiology ; stress ; Stress, Psychological - complications ; Stress, Psychological - physiopathology</subject><ispartof>Psychiatry and clinical neurosciences, 2014-01, Vol.68 (1), p.1-20</ispartof><rights>2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology</rights><rights>2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.</rights><rights>Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5116-662d55356a3866cc59d42ffd99285a5a7280ddc3a7c17517d6bb04349665138d3</citedby><cites>FETCH-LOGICAL-c5116-662d55356a3866cc59d42ffd99285a5a7280ddc3a7c17517d6bb04349665138d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpcn.12126$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpcn.12126$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,1434,27929,27930,45579,45580,46414,46838</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24372896$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Ken‐ichi</creatorcontrib><creatorcontrib>Shinba, Toshikazu</creatorcontrib><creatorcontrib>Yoshii, Mitsunobu</creatorcontrib><title>Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view</title><title>Psychiatry and clinical neurosciences</title><addtitle>Psychiatry Clin Neurosci</addtitle><description>What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti‐noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long‐term noradrenergic dysfunction.</description><subject>Adrenergic Neurons - drug effects</subject><subject>Adrenergic Neurons - pathology</subject><subject>Animals</subject><subject>Anti-Anxiety Agents - pharmacology</subject><subject>Anti-Anxiety Agents - therapeutic use</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Anxiety</subject><subject>Arousal - drug effects</subject><subject>Arousal - physiology</subject><subject>Behavioral Symptoms - drug therapy</subject><subject>Behavioral Symptoms - physiopathology</subject><subject>Humans</subject><subject>hyperarousal symptoms</subject><subject>Hypotheses</subject><subject>locus coeruleus</subject><subject>Mental Disorders - complications</subject><subject>Mental Disorders - drug therapy</subject><subject>Mental Disorders - physiopathology</subject><subject>Mental Disorders - psychology</subject><subject>noradrenaline</subject><subject>pathophysiology</subject><subject>stress</subject><subject>Stress, Psychological - complications</subject><subject>Stress, Psychological - physiopathology</subject><issn>1323-1316</issn><issn>1440-1819</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0U9LwzAYBvAgipvTg19ACl700C1v0qSttzH8B0N30HPJktR1tE1NWke_vZmbHgTBXBJ4fzwkeRA6BzwGvyaNrMdAgPADNIQowiEkkB76MyU0BAp8gE6cW2OMKeVwjAYkojFJUj5E84Xr5aoQrS1k4PqqaU3lApMHtbFCWV1r--Ynqnd5V8u2MPVNMA0a0a5Ms-pdYUrj56IMPgq9OUVHuSidPtvvI_R6d_syewjnz_ePs-k8lAyAh5wTxRhlXNCEcylZqiKS5ypNScIEE_5qWClJRSwhZhArvlziiEYp5wxoougIXe1yG2veO-3arCqc1GUpam06l0GUEk4oifl_KI5xQviWXv6ia9PZ2j_EqzhimGAgXl3vlLTGOavzrLFFJWyfAc62bWS-jeyrDW8v9ondstLqR35_vweTHdgUpe7_TsoWs6dd5CeGA5Hr</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>Yamamoto, Ken‐ichi</creator><creator>Shinba, Toshikazu</creator><creator>Yoshii, Mitsunobu</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201401</creationdate><title>Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view</title><author>Yamamoto, Ken‐ichi ; Shinba, Toshikazu ; Yoshii, Mitsunobu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5116-662d55356a3866cc59d42ffd99285a5a7280ddc3a7c17517d6bb04349665138d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adrenergic Neurons - drug effects</topic><topic>Adrenergic Neurons - pathology</topic><topic>Animals</topic><topic>Anti-Anxiety Agents - pharmacology</topic><topic>Anti-Anxiety Agents - therapeutic use</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Anxiety</topic><topic>Arousal - drug effects</topic><topic>Arousal - physiology</topic><topic>Behavioral Symptoms - drug therapy</topic><topic>Behavioral Symptoms - physiopathology</topic><topic>Humans</topic><topic>hyperarousal symptoms</topic><topic>Hypotheses</topic><topic>locus coeruleus</topic><topic>Mental Disorders - complications</topic><topic>Mental Disorders - drug therapy</topic><topic>Mental Disorders - physiopathology</topic><topic>Mental Disorders - psychology</topic><topic>noradrenaline</topic><topic>pathophysiology</topic><topic>stress</topic><topic>Stress, Psychological - complications</topic><topic>Stress, Psychological - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Ken‐ichi</creatorcontrib><creatorcontrib>Shinba, Toshikazu</creatorcontrib><creatorcontrib>Yoshii, Mitsunobu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry and clinical neurosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Ken‐ichi</au><au>Shinba, Toshikazu</au><au>Yoshii, Mitsunobu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view</atitle><jtitle>Psychiatry and clinical neurosciences</jtitle><addtitle>Psychiatry Clin Neurosci</addtitle><date>2014-01</date><risdate>2014</risdate><volume>68</volume><issue>1</issue><spage>1</spage><epage>20</epage><pages>1-20</pages><issn>1323-1316</issn><eissn>1440-1819</eissn><abstract>What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti‐noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long‐term noradrenergic dysfunction.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>24372896</pmid><doi>10.1111/pcn.12126</doi><tpages>20</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1323-1316
ispartof Psychiatry and clinical neurosciences, 2014-01, Vol.68 (1), p.1-20
issn 1323-1316
1440-1819
language eng
recordid cdi_proquest_miscellaneous_1492623276
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Open Access Titles of Japan; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection
subjects Adrenergic Neurons - drug effects
Adrenergic Neurons - pathology
Animals
Anti-Anxiety Agents - pharmacology
Anti-Anxiety Agents - therapeutic use
Antipsychotic Agents - pharmacology
Antipsychotic Agents - therapeutic use
Anxiety
Arousal - drug effects
Arousal - physiology
Behavioral Symptoms - drug therapy
Behavioral Symptoms - physiopathology
Humans
hyperarousal symptoms
Hypotheses
locus coeruleus
Mental Disorders - complications
Mental Disorders - drug therapy
Mental Disorders - physiopathology
Mental Disorders - psychology
noradrenaline
pathophysiology
stress
Stress, Psychological - complications
Stress, Psychological - physiopathology
title Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T00%3A01%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psychiatric%20symptoms%20of%20noradrenergic%20dysfunction:%20A%20pathophysiological%20view&rft.jtitle=Psychiatry%20and%20clinical%20neurosciences&rft.au=Yamamoto,%20Ken%E2%80%90ichi&rft.date=2014-01&rft.volume=68&rft.issue=1&rft.spage=1&rft.epage=20&rft.pages=1-20&rft.issn=1323-1316&rft.eissn=1440-1819&rft_id=info:doi/10.1111/pcn.12126&rft_dat=%3Cproquest_cross%3E1490708266%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1474502012&rft_id=info:pmid/24372896&rfr_iscdi=true